InvestorsHub Logo
Followers 51
Posts 9121
Boards Moderated 1
Alias Born 10/25/2007

Re: Man6677 post# 11806

Tuesday, 06/07/2022 11:36:34 AM

Tuesday, June 07, 2022 11:36:34 AM

Post# of 13510
In a report released today, Leah R. Cann from Brookline Capital Markets maintained a Buy rating on Moderna (MRNA – Research Report), with a price target of $506.00

https://www.tipranks.com/news/blurbs/moderna-mrna-gets-a-buy-rating-from-brookline-capital-markets?utm_source=advfn.com&utm_medium=referral
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News